Here's Why Madison Investors Fund Sold Becton, Dickinson and Company (BDX)
Least Shorted S&P 500 Stocks in June
Looking Into Becton Dickinson's Recent Short Interest
Becton Dickinson's (NYSE:BDX) short percent of float has risen 17.65% since its last report. The company recently reported that it has 2.32 million shares sold short, which is 0.8% of all regular
With 87% Institutional Ownership, Becton, Dickinson and Company (NYSE:BDX) Is a Favorite Amongst the Big Guns
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions The top 22 shareholders own 50% of the company
Becton Dickinson Warns of Blood Culture Product Delays
UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades'
Jim Lebenthal of Cerity Partners hyped UnitedHealth Group Incorporated (NYSE:UNH) as a "solid" healthcare company in the latest edition of CNBC's "Halftime Report Final Trades." On July 9, Cantor
Wells Fargo Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $290
Wells Fargo analyst Larry Biegelsen maintains $Becton Dickinson & Co(BDX.US)$ with a buy rating, and maintains the target price at $290.According to TipRanks data, the analyst has a success rate of 58
Express News | Citigroup Maintains Neutral on Becton Dickinson, Lowers Price Target to $255
Becton Dickinson's Stock Bounces as FDA Addresses Supply Issue With Blood-culture Vials
By Tomi Kilgore Medical-supply company looks to fill gaps as former supplier restarts production of vials Shares of Becton Dickinson & Co. bounced back Wednesday toward their first gain in seven
Express News | BD Committed To Global Health; Mitigating Blood Culture Vial Supplier Issue With FDA Collaboration, Rapid Production, And Restarting Glass Vial Production; Manual Allocation To Prioritize Clinical Needs; No Material Financial Impact Expected
Express News | Bd - Bd Bactec Blood Culture Vials Being Allocated Manually to Best Mitigate Any Impact to Patient Care
Express News | Bd: Co's Former Supplier of Glass Vials Will Restart Production to Help Fill Intermittent Gap in Supply
Express News | Bd: Experiencing Reduced Availability of Blood Culture Vials From Our Supplier
Express News | Bd - Supplier Issue Is Not Expected to Have a Material Financial Impact on Bd
Express News | Bd Statement on Supplier Issue Impacting Bd Bactec™ Blood Culture Vials
Express News | FDA: Disruption in Supply of Bd Bactec Blood Culture Media Bottles in U.S. Expected to Impact Patient Diagnosis, Follow up Patient Management
Express News | FDA Says Aware That U.S. Is Experiencing Interruptions In The Supply Of BD BACTEC Blood Culture Media Bottles Because Of Recent Supplier Issues
Express News | FDA: Aware That U.S. Is Experiencing Interruptions in the Supply of Bd Bactec Blood Culture Media Bottles Because of Recent Supplier Issues
Goldman Sachs Adjusts Price Target on Becton, Dickinson to $262 From $274
Becton, Dickinson (BDX) has an average outperform rating and a price target range of $240 to $325, according to analysts polled by Capital IQ.Price: 221.59, Change: +0.12, Percent Change: +0.05
Citi Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $255
Citi analyst Joanne Wuensch maintains $Becton Dickinson & Co(BDX.US)$ with a hold rating, and adjusts the target price from $260 to $255.According to TipRanks data, the analyst has a success rate of 6